Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Nephro Care India IPO is a book built issue of Rs 41.26 crores. The issue is entirely a fresh issue of 45.84 lakh shares.
Nephro Care India IPO bidding opened for subscription on June 28, 2024 and will close on July 2, 2024. The allotment for the Nephro Care India IPO is expected to be finalized on Wednesday, July 3, 2024. Nephro Care India IPO will list on NSE SME with tentative listing date fixed as Friday, July 5, 2024.
Nephro Care India IPO price band is set at ₹85 to ₹90 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹144,000. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹288,000.
Corporate Capitalventures Pvt Ltd is the book running lead manager of the Nephro Care India IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Nephro Care India IPO is Ss Corporate Securities.
Refer to Nephro Care India IPO RHP for detailed information.
| IPO Date | June 28, 2024 to July 2, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹85 to ₹90 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Fresh Issue | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 11,902,400 |
| Share holding post issue | 16,486,400 |
| Market Maker portion | 230,400 shares Ss Corporate Securities |
Nephro Care India IPO offers 4,584,000 shares. 825,600 (18.01%) to QIB, 619,200 (13.51%) to NII, 1,444,800 (31.52%) to RII and 1,238,400 (27.02%) to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | 1,238,400 (27.02%) |
| Market Maker Shares Offered | 230,400 (5.03%) |
| QIB Shares Offered | 825,600 (18.01%) |
| NII (HNI) Shares Offered | 619,200 (13.51%) |
| Retail Shares Offered | 1,444,800 (31.52%) |
| Total Shares Offered | 4,584,000 (100%) |
Nephro Care India IPO raises Rs 11.15 crore from anchor investors. Nephro Care India IPO Anchor bid date is June 27, 2024. Nephro Care India IPO Anchor Investors list
| Bid Date | June 27, 2024 |
| Shares Offered | 1,238,400 |
| Anchor Portion Size (In Cr.) | 11.15 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 2, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 1, 2024 |
Nephro Care India IPO opens on June 28, 2024, and closes on July 2, 2024.
| IPO Open Date | Friday, June 28, 2024 |
| IPO Close Date | Tuesday, July 2, 2024 |
| Basis of Allotment | Wednesday, July 3, 2024 |
| Initiation of Refunds | Thursday, July 4, 2024 |
| Credit of Shares to Demat | Thursday, July 4, 2024 |
| Listing Date | Friday, July 5, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 2, 2024 |
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹144,000 |
| Retail (Max) | 1 | 1600 | ₹144,000 |
| HNI (Min) | 2 | 3,200 | ₹288,000 |
| Lot Size Calculator | |||
The company promoter is Dr. Pratim Sengupta.
| Share Holding Pre Issue | 85.02% |
| Share Holding Post Issue | 61.39% |
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.
Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.
Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
At present, Nephro Care offers the following services at its clinics:
As of March 31, 2024 the hospital employs 110 people in various departments.
Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 2,029.85 | 831.11 | 462.93 | 112.84 |
| Revenue | 1,989.60 | 1,709.51 | 342.70 | 183.26 |
| Profit After Tax | 340.04 | 194.24 | -0.98 | 8.87 |
| Net Worth | 1,392.32 | 243.76 | 49.52 | 1.50 |
| Reserves and Surplus | 1,332.81 | 193.76 | -0.48 | 0.50 |
| Total Borrowing | 246.39 | 253.74 | 69.27 | |
| Amount in ₹ Lakhs | ||||
The market capitalization of Nephro Care India IPO is Rs 148.38 Cr.
KPI as of December 31, 2023.
| KPI | Values |
|---|---|
| ROE | 41.57% |
| ROCE | 36.56% |
| RoNW | 24.42% |
| P/BV | 8.04 |
| PAT Margin (%) | 17.22 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.63 | 2.75 |
| P/E (x) | 55.15 | 32.73 |
The company intends to utilize the Net Fresh Issue Proceeds for the following Objects
[Dilip Davda] The company is engaged in providing healthcare services with renal insufficiency treatment. It marked inconsistency in its net earnings for the reported periods and the sudden surge in bottom in for 9M-FY24 raise eyebrows and concern over its sustainability going forward. Based on its super annualized FY24 earnings, the issue appears aggressively priced. There is no harm in skipping this pricey bet. Read detail review...
The Nephro Care India IPO is subscribed 16.84 times on June 28, 2024 7:29:55 PM. The public issue subscribed 30.20 times in the retail category, 0.09 times in the QIB category, and 14.13 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 0.09 |
| NII | 14.13 |
| Retail | 30.20 |
| Total | 16.84 |
Total Application : 27,273 (30.20 times)
Nephro Care India Limited
Flat No-1JC-18, 5th Floor Sec-III
Salt lake Kolkata, Bidhan Nagar Sai Complex,
North 24 Parganas -700098
Phone: +91 8017010197
Email: cs@nephrocareindia.com/
Website: https://www.nephrocareindia.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Nephro Care India IPO is a SME IPO of 4,584,000 equity shares of the face value of ₹10 aggregating up to ₹41.26 Crores. The issue is priced at ₹85 to ₹90 per share. The minimum order quantity is 1600 Shares.
The IPO opens on June 28, 2024, and closes on July 2, 2024.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Nephro Care India IPO using UPI as a payment gateway. Zerodha customers can apply in Nephro Care India IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Nephro Care India IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Nephro Care India IPO opens on June 28, 2024 and closes on July 2, 2024.
Nephro Care India IPO lot size is 1600 Shares, and the minimum amount required is ₹144,000.
You can apply in Nephro Care India IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Nephro Care India IPO will be done on Wednesday, July 3, 2024, and the allotted shares will be credited to your demat account by Thursday, July 4, 2024. Check the Nephro Care India IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
